Lv1
40 积分 2022-07-22 加入
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)
1个月前
已完结
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
1个月前
已完结
Neoadjuvant chemotherapy for ovarian cancer: Avoiding ‘needless hurt’?
1个月前
已完结
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial
1个月前
已完结
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
2个月前
已完结
Sentinel lymph node mapping in early-stage ovarian cancer: surgical technique in 10 steps
2个月前
已完结
Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer
2个月前
已完结
Sentinel lymph nodes (SLN) in endometrial cancer: The relationship between primary tumor histology, SLN metastasis size, and non-sentinel node metastasis
2个月前
已完结
Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer
2个月前
已完结
Sentinel node detection and imaging concordance in Early-Stage ovarian cancer: A MELISA trial analysis of tracer, timing, and intraoperative gamma camera
2个月前
已完结
皖公网安备34019202002308
